References
- Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocar-dial infarction intervention trials. Am J Cardiol. 1986;57:F43–F49.
- Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J. 1999;1 Suppl:H64–H69.
- Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, . Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation. 2001;103:1428–1433.
- Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J. 1993;125: 1148–1154.
- Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, . The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J. 1986;7:279–288.
- Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001;50:373–378.
- Hozawa A, Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K, . Predictive value of ambulatory heart rate in the Japanese general population: The Ohasama study. J Hypertens. 2008;26:1571–1576.
- López-Sendón JL; López de Sá E. Reducción de la frecuencia cardiaca. Otras oportunidades terapéuticas. Rev Esp Cardiol. 2007;7:53–57.
- Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernández del Rey R, .; for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–984.
- O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. Br Med J. 2001; 322:531–536.
- Topouchian JA, El Assaad MA, Orobinskaia LY, El Feghali RN, Asmar RG. Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: The Omron M6 (HEM-7001-E) and the Omron R7 (HEM-637--IT). Blood Press Monit. 2006;11:165–171.
- Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, . Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142–161.
- Ferrari R, Campo G, Gardini E, Pasanisi G, Ceconi C. Specific and selective If inhibition: Expected clinical benefits from pure heart rate reduction in coronary patients. Eur Heart J. 2005;7Suppl H:16–21.
- Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, . Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–749.
- Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J. 1985;109:876–885.
- Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: Associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J. 1988;116:163–174.
- Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J. 1993;70:49–55.
- Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation. 1999;99:1978–1983.
- Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: A risk factor for cardiovascular death in elderly men. Arch Intern Med. 1999;159:585–592.
- Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3–17.
- Erikssen J, Rodahl K. Resting heart rate in apparently healthy middle-aged men. Eur J Appl Physiol Occup Physiol. 1979;42:61–69.
- Berenson GS, Voors AW, Webber LS, Dalferes ER Jr, Harsha DW. Racial differences of parameters associated with blood pressure levels in children — The Bogalusa heart study. Metabolism. 1979;28:1218–1228.
- Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, . Resting heart rate is a risk factor for cardiovascular and non-cardiovascular mortality: The Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1999;149:853–862.
- Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J. 2000;21: 116–124.
- Mo R, Nordrehaug JE, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study: Prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press. 1995;4:16–22.
- Hansen TW, Thijs L, Boggia J, Li Y, Kikuya M, Björklund-Bodegård K, .; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 2008;52:229–235.